Cargando…
Impact of relative dose intensity on bone marrow suppression induced by S-1: retrospective observational study
BACKGROUND: S-1 (a combination of tegafur, gimeracil, and oteracil) is used to treat various cancers. Bone marrow suppression is a dose-limiting toxicity of S-1. The relationship between relative dose intensity (RDI) and bone marrow suppression has not been investigated. Hence, we aimed to elucidate...
Autores principales: | Hirai, Toshinori, Ogawa, Ryuichi, Yamaga, Ryosuke, Itoh, Toshimasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276246/ https://www.ncbi.nlm.nih.gov/pubmed/30524750 http://dx.doi.org/10.1186/s40780-018-0127-x |
Ejemplares similares
-
Characteristics of risk factors for acute kidney injury among inpatients administered sulfamethoxazole/trimethoprim: a retrospective observational study
por: Shimizu, Yuki, et al.
Publicado: (2022) -
A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales
por: Ogawa, Yukari, et al.
Publicado: (2021) -
Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
por: Bao, Zhirong, et al.
Publicado: (2019) -
Malignant Pleural Mesothelioma with Bone Marrow Metastases
por: Ihara, Hiroaki, et al.
Publicado: (2018) -
Constitutive bone marrow adipocytes suppress local bone formation
por: Li, Ziru, et al.
Publicado: (2022)